Geode Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,629,759
| Closed | -$15.6M | – | 4565 |
|
|
2024
Q4 | $15.6M | Buy |
1,629,759
+12,622
| +0.8% | +$121K | ﹤0.01% | 2091 |
|
|
2024
Q3 | $4.63M | Sell |
1,617,137
-5,438
| -0.3% | -$15.6K | ﹤0.01% | 2797 |
|
|
2024
Q2 | $4.74M | Buy |
1,622,575
+59,215
| +4% | +$173K | ﹤0.01% | 2758 |
|
|
2024
Q1 | $4.99M | Buy |
1,563,360
+40,305
| +3% | +$129K | ﹤0.01% | 2707 |
|
|
2023
Q4 | $5.12M | Buy |
1,523,055
+104,738
| +7% | +$352K | ﹤0.01% | 2695 |
|
|
2023
Q3 | $3.38M | Buy |
1,418,317
+193,750
| +16% | +$461K | ﹤0.01% | 2843 |
|
|
2023
Q2 | $2.16M | Buy |
1,224,567
+718,477
| +142% | +$1.26M | ﹤0.01% | 3087 |
|
|
2023
Q1 | $1.56M | Buy |
506,090
+14,618
| +3% | +$45K | ﹤0.01% | 3137 |
|
|
2022
Q4 | $2.6M | Buy |
491,472
+36,420
| +8% | +$193K | ﹤0.01% | 2941 |
|
|
2022
Q3 | $1.61M | Buy |
455,052
+192,571
| +73% | +$680K | ﹤0.01% | 3160 |
|
|
2022
Q2 | $677K | Sell |
262,481
-240,551
| -48% | -$620K | ﹤0.01% | 3594 |
|
|
2022
Q1 | $2.25M | Buy |
503,032
+12,433
| +3% | +$55.7K | ﹤0.01% | 3205 |
|
|
2021
Q4 | $3.34M | Buy |
490,599
+113,850
| +30% | +$775K | ﹤0.01% | 3114 |
|
|
2021
Q3 | $2.75M | Buy |
376,749
+205
| +0.1% | +$1.49K | ﹤0.01% | 3220 |
|
|
2021
Q2 | $3.77M | Sell |
376,544
-26,249
| -7% | -$263K | ﹤0.01% | 3064 |
|
|
2021
Q1 | $3.85M | Buy |
402,793
+189,886
| +89% | +$1.81M | ﹤0.01% | 2911 |
|
|
2020
Q4 | $2.34M | Buy |
212,907
+24,067
| +13% | +$264K | ﹤0.01% | 3000 |
|
|
2020
Q3 | $1.68M | Buy |
+188,840
| New | +$1.68M | ﹤0.01% | 2965 |
|